Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Operating Leases (2021 - 2025)

Historic Operating Leases for Beauty Health (SKIN) over the last 5 years, with Q3 2025 value amounting to $10.6 million.

  • Beauty Health's Operating Leases fell 1275.12% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year decrease of 1275.12%. This contributed to the annual value of $10.8 million for FY2024, which is 2230.37% down from last year.
  • Beauty Health's Operating Leases amounted to $10.6 million in Q3 2025, which was down 1275.12% from $8.5 million recorded in Q2 2025.
  • Beauty Health's Operating Leases' 5-year high stood at $17.6 million during Q4 2022, with a 5-year trough of $8.5 million in Q2 2025.
  • Moreover, its 5-year median value for Operating Leases was $12.1 million (2022), whereas its average is $12.2 million.
  • Its Operating Leases has fluctuated over the past 5 years, first soared by 1967.34% in 2024, then plummeted by 3332.81% in 2025.
  • Quarter analysis of 5 years shows Beauty Health's Operating Leases stood at $16.5 million in 2021, then grew by 7.0% to $17.6 million in 2022, then fell by 21.14% to $13.9 million in 2023, then fell by 22.3% to $10.8 million in 2024, then dropped by 2.42% to $10.6 million in 2025.
  • Its last three reported values are $10.6 million in Q3 2025, $8.5 million for Q2 2025, and $9.6 million during Q1 2025.